Author

Ming‐Shien Wen

Chang Gung UniversityORCID 0000-0002-0056-7985Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Bu‐Yuan HsiaoiD· 1 shared Cathy S.-J. FanniD· 1 shared Chang‐Fu KuoiD· 1 shared Chao‐Wei LeeiD· 1 shared Chau‐Chyun SheuiD· 1 shared Chaur‐Jong HuiD· 1 shared Chia-Lin Tsai· 1 shared Chia‐Kuang TsaiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Bu‐Yuan HsiaoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort

Chun-Yu Wei, Ming‐Shien Wen, Chih-Kuang Cheng, Yi‐Jing Sheen, Tsung‐Chieh Yao, Sing-Lian Lee, Jer-Yuarn Wu, Ming-Fang Tsai, Ling-Hui Li, Chun‐Houh Chen, Cathy S.-J. Fann, Hsin‐Chou Yang, Yen‐Tsung Huang, Hung-Hsin Chen, Yi-Min Liu, , Chien‐Ming Lin

The paper evaluates the clinical impact of pharmacogenetic risk variants in a large Han Chinese cohort, finding that while most carry risk variants, the excess risk of adverse events is small and most patients do not experience adverse outcomes.

Nature Communications · Jul 9, 2025Peer-reviewedGenetic & Genomic Medicine